TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely May 23, 2003
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
